Evidence map›Paper›PMID 40937507›Full record

SynthesisJournal of cachexia, sarcopenia and muscle2025

Enhancing Muscle Quality: Exploring Leucine and Whey Protein in Sarcopenic Individuals.

Aiman Ijaz, Huma Bader Ul Ain, Tabussam Tufail, Raima Mariam, Sana Noreen, Aniqa Amjad, Ali Ikram, Muhammad Tayyab Arshad, Muhammed Adem Abdullahi

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of cachexia, sarcopenia and muscle, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Parthenolide Attenuates Skeletal Muscle Atrophy Through Regulation of Protein Homeostasis and Inhibition of Inflammation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aiman IjazUniversity Institute of Diet and Nutritional Sciences, The University of Lahore, Lahore, Pakistan.
Huma Bader Ul AinUniversity Institute of Diet and Nutritional Sciences, The University of Lahore, Lahore, Pakistan.
Tabussam TufailUniversity Institute of Diet and Nutritional Sciences, The University of Lahore, Lahore, Pakistan.
Raima MariamUniversity Institute of Diet and Nutritional Sciences, The University of Lahore, Lahore, Pakistan.
Sana NoreenUniversity Institute of Diet and Nutritional Sciences, The University of Lahore, Lahore, Pakistan.
Aniqa AmjadUniversity Institute of Diet and Nutritional Sciences, The University of Lahore, Lahore, Pakistan.
Ali IkramUniversity Institute of Food Science and Technology, The University of Lahore, Lahore, Pakistan.
Muhammad Tayyab ArshadUniversity Institute of Food Science and Technology, The University of Lahore, Lahore, Pakistan.
Muhammed Adem AbdullahiDepartment of Food Science and Postharvest Technology, College of Agriculture and Veterinary Medicine, Jimma University, Ethiopia.ORCID 0009-0003-4121-3256

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSarcopenia is characterised by a decline in the skeletal muscle mass with increasing age. This poses many challenges to the health and independence of older individuals. New and emerging studies have focused on supplementing leucine-enriched whey protein and resistance training in older adults to mitigate the effects of sarcopenia, including significant muscle mass loss.

methodsThis study aimed to comprehensively analyse the current literature regarding the beneficial effects of leucine-enriched whey protein supplementation in older adults. This article systematically reviewed randomised controlled trials, longitudinal studies, and meta-analyses published between 2011 and 2024. The biochemical mechanisms underlying the anabolic properties of leucine, including its role in protein synthesis and mTOR signalling pathways, were explored to elucidate its potential to enhance muscle protein accretion.

resultsFindings from the reviewed studies indicate that the combined intervention of leucine-enriched whey protein supplementation and resistance training elicits favourable outcomes regarding increased lean muscle mass, muscle strength and physical performance in older adults with sarcopenia. The potential of leucine-enriched whey protein to mitigate muscle protein breakdown is discussed along with its potential synergistic effects with resistance exercise to optimise muscle adaptation. Future research directions, including investigations of optimal dosing regimens, long-term sustainability and potential contraindications, are proposed to enhance the precision and applicability of this intervention strategy.

conclusionLeucine-enriched whey protein supplementation combined with resistance training is beneficial in addressing sarcopenia in older adults. This review consolidates the current understanding of this intervention, highlights its potential benefits and provides insights for future research and clinical applications in geriatric muscle health.

Indexed as

LeucineMuscle, SkeletalSarcopeniaWhey ProteinsAgedDietary SupplementsHumansRandomized Controlled Trials as TopicResistance TrainingLeucineWhey ProteinsmTOR signalling pathwaymuscle healthwhey protein

Identifiers

PMID40937507
PMCPMC12426612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.